The first new PTSD drug in over twenty years is up for approval. It will require US regulators to do something they’ve never done before: greenlight the mind-altering — and illegal — party drug known as ecstasy.
The new drug is a version of MDMA, also known as ecstasy, made by Lykos Therapeutics Inc., an unusual drugmaker started by a nonprofit that has for decades advocated to bring psychedelic therapy to the masses.
On June 4, the public will gain the first hint of how regulators are leaning when outside experts on the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.